FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020159664> ?p ?o ?g. }

• W2020159664 endingPage "1651" @default.
• W2020159664 startingPage "1627" @default.
• W2020159664 abstract "Importance of the field: Type 2 diabetes is a chronic disease characterized by the development of insulin resistance, impaired pancreatic β-cell function and, ultimately, hyperglycemia. The disease is highly associated with obesity and it is thought that the inappropriate deposition of lipid in tissues such as liver and muscle contributes to a reduction in insulin sensitivity which, in turn, places a burden on the β-cell to secrete more insulin to achieve normoglycemia. Over an extended period of time, this can result in β-cell failure and diminished glycemic control. When poorly managed, type 2 diabetes increases the risk of developing both microvascular and macrovascular complications, including retinopathy, nephropathy and coronary artery disease. The number of Americans with diabetes has approached 24 million in 2007 and the prevalence of the disease is projected to increase with the sedentary lifestyles and high caloric diets that are common today. First-line treatment for the disease involves lifestyle modifications and, if unsuccessful, pharmacotherapy to control symptoms. Anti-diabetic drugs belonging to several mechanistic classes are available (e.g., insulin secretagogues, insulin sensitizers, insulin mimetics and DPP IV inhibitors); however, many of these drugs lose their effectiveness over time, are not well-tolerated in some patients or may have suboptimal risk:benefit ratios. The search for new anti-diabetic drugs has continued to attract considerable interest from both academia and the pharmaceutical industry. Areas covered in this review: An analysis of 2008 – 2010 patent applications claiming diabetes as an indication has been undertaken. What the reader will gain: An understanding of: i) the pharmaceutical companies that have filed patent applications in the anti-diabetes area during 2008 – 2010; ii) the different pharmacological targets under investigation and the patent activity around such targets; iii) some of the targets in the research portfolios of selected companies; iv) chemical structures of compounds that modulate emerging targets and v) the pharmacological rationale underlying several targets with the largest patent counts. Take home message: Type 2 diabetes is a complex disease with many potential points of intervention for pharmacotherapy. A majority of anti-diabetic patent applications claim chemical matter for just eight targets which include five enzymes, a GPCR, a family of nuclear hormone receptors and a class of sodium-dependent glucose co-transporters (11β-HSD1, DGAT1, DPP IV, glucokinase, GPR119, PPAR-α, -δ, -γ, SGLT1 and SGLT2, and stearoyl-CoA desaturase 1 (SCD1)). The major pharmaceutical companies are all pursuing some combination of these top eight targets. Several companies stand out for the breadth of new targets under investigation (e.g., F. Hoffmann-La Roche, Merck & Co., Pfizer, Takeda Pharmaceuticals, Sanofi-Aventis)." @default.
• W2020159664 created "2016-06-24" @default.
• W2020159664 creator A5035773588 @default.
• W2020159664 creator A5043120561 @default.
• W2020159664 date "2010-11-18" @default.
• W2020159664 modified "2023-09-26" @default.
• W2020159664 title "Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literature" @default.
• W2020159664 cites W1578442529 @default.
• W2020159664 cites W1589976311 @default.
• W2020159664 cites W1964013137 @default.
• W2020159664 cites W1967667786 @default.
• W2020159664 cites W1968682237 @default.
• W2020159664 cites W1971639453 @default.
• W2020159664 cites W1971779847 @default.
• W2020159664 cites W1974708093 @default.
• W2020159664 cites W1975045088 @default.
• W2020159664 cites W1982600501 @default.
• W2020159664 cites W1986517810 @default.
• W2020159664 cites W1989335796 @default.
• W2020159664 cites W1994741408 @default.
• W2020159664 cites W1995573327 @default.
• W2020159664 cites W2002760082 @default.
• W2020159664 cites W2003687262 @default.
• W2020159664 cites W2006746802 @default.
• W2020159664 cites W2007486805 @default.
• W2020159664 cites W2007527212 @default.
• W2020159664 cites W2012898950 @default.
• W2020159664 cites W2013481385 @default.
• W2020159664 cites W2021943148 @default.
• W2020159664 cites W2023018609 @default.
• W2020159664 cites W2029646361 @default.
• W2020159664 cites W2036227043 @default.
• W2020159664 cites W2039890062 @default.
• W2020159664 cites W2040687831 @default.
• W2020159664 cites W2041624484 @default.
• W2020159664 cites W2041780259 @default.
• W2020159664 cites W2045343006 @default.
• W2020159664 cites W2046188044 @default.
• W2020159664 cites W2046672585 @default.
• W2020159664 cites W2048636541 @default.
• W2020159664 cites W2049355275 @default.
• W2020159664 cites W2050455735 @default.
• W2020159664 cites W2050605495 @default.
• W2020159664 cites W2056277685 @default.
• W2020159664 cites W2063388729 @default.
• W2020159664 cites W2064249167 @default.
• W2020159664 cites W2065034018 @default.
• W2020159664 cites W2066338366 @default.
• W2020159664 cites W2066928947 @default.
• W2020159664 cites W2067249361 @default.
• W2020159664 cites W2067346786 @default.
• W2020159664 cites W2076025331 @default.
• W2020159664 cites W2076641946 @default.
• W2020159664 cites W2077257470 @default.
• W2020159664 cites W2077936393 @default.
• W2020159664 cites W2081276121 @default.
• W2020159664 cites W2084320367 @default.
• W2020159664 cites W2086355314 @default.
• W2020159664 cites W2086635975 @default.
• W2020159664 cites W2089540591 @default.
• W2020159664 cites W2090415246 @default.
• W2020159664 cites W2092020543 @default.
• W2020159664 cites W2093519481 @default.
• W2020159664 cites W2095612977 @default.
• W2020159664 cites W2096329362 @default.
• W2020159664 cites W2096726403 @default.
• W2020159664 cites W2098889553 @default.
• W2020159664 cites W2099110406 @default.
• W2020159664 cites W2102964449 @default.
• W2020159664 cites W2103196856 @default.
• W2020159664 cites W2104920038 @default.
• W2020159664 cites W2109069233 @default.
• W2020159664 cites W2114853986 @default.
• W2020159664 cites W2115276803 @default.
• W2020159664 cites W2117268230 @default.
• W2020159664 cites W2117807487 @default.
• W2020159664 cites W2119251936 @default.
• W2020159664 cites W2120242787 @default.
• W2020159664 cites W2124464501 @default.
• W2020159664 cites W2124557239 @default.
• W2020159664 cites W2127374120 @default.
• W2020159664 cites W2128326754 @default.
• W2020159664 cites W2129546749 @default.
• W2020159664 cites W2130400490 @default.
• W2020159664 cites W2132079328 @default.
• W2020159664 cites W2132377842 @default.
• W2020159664 cites W2133816037 @default.
• W2020159664 cites W2138202978 @default.
• W2020159664 cites W2138226825 @default.
• W2020159664 cites W2138309074 @default.
• W2020159664 cites W2138437384 @default.
• W2020159664 cites W2139907919 @default.
• W2020159664 cites W2142360957 @default.
• W2020159664 cites W2144173715 @default.
• W2020159664 cites W2145084780 @default.
• W2020159664 cites W2149185387 @default.
• W2020159664 cites W2150654293 @default.
• W2020159664 cites W2150925908 @default.

• next